Navigation Links
Mersana Therapeutics Appoints Michael A. Metzger as EVP & COO
Date:4/20/2011

CAMBRIDGE, Mass., April 20, 2011 /PRNewswire/ -- Mersana Therapeutics, a platform-based cancer therapeutics company, today announced that Michael A. Metzger has joined the company as Executive Vice President & Chief Operating Officer.  In this role, he will oversee corporate and business development strategy and planning, as well as finance and other business operations of the company.  Mr. Metzger was previously a senior member of the business development team at Forest Laboratories, Inc., where he led the company's M&A activities.

"We are very pleased to welcome Michael to the management team at Mersana," said Nicholas Bacopoulos, Ph.D., Chief Executive Officer of Mersana.  "His broad experience in all aspects of corporate and business development and successful M&A track record will be extremely valuable to Mersana as we continue to advance our drug pipeline and Fleximer®-based platform initiatives both internally and through collaborations."

"I am excited to join Mersana as it is poised to exploit its unique Fleximer polymer platform into next-generation oncology products," said Mr. Metzger.  "As the Fleximer platform has already led to the development of two clinical-stage oncology compounds and has demonstrated proof-of-concept with other therapeutic approaches such as peptides, antibody drug conjugates and RNAi delivery, the potential for significant corporate partnerships is especially promising."

Mr. Metzger brings to Mersana nearly 20 years of experience within the life sciences and pharmaceuticals industries.  At Forest Laboratories, he spearheaded the mergers and acquisitions function and most recently led the successful acquisition of Clinical Data, Inc. for $1.2 billion. During his tenure at Forest, Mr. Metzger also completed transformative deals with Cerexa, which was acquired in 2007 for $482 million, and Novexel, which together formed the cornerstone of Forest's hospital antibiotic fr
'/>"/>

SOURCE Mersana Therapeutics, Inc.
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2

Related medicine technology :

1. Mersana Therapeutics Initiates Phase 1b Extension Study of XMT-1001 in Gastric Cancer and Non-Small Cell Lung Cancer
2. Mersana Therapeutics Provides Clinical Update from Ongoing Phase 1 Study of XMT-1001 in Patients with Advanced Solid Tumors
3. Mersana Therapeutics Reports Phase I Results for XMT-1001 in Patients with Solid Tumors at AACR-NCI-EORTC International Conference
4. Amicus Therapeutics Announces Transition of John F. Crowley from Chairman and Chief Executive Officer to Executive Chairman
5. CoDa Therapeutics Closes $19 Million Series B Financing Round
6. Reportlinker Adds Endometrial Cancer Therapeutics - Pipeline Assessment and Market Forecasts to 2017
7. Reportlinker Adds Bone Metastases Therapeutics - Pipeline Assessment and Market Forecasts to 2017
8. Reportlinker Adds Juvenile Rheumatoid Arthritis (JRA) Therapeutics - Pipeline Assessment and Market Forecasts to 2017
9. Oxford BioTherapeutics Licenses BioWas POTELLIGENT® Technology for the Research and Development of its Therapeutic Antibodies in Cancer
10. Medicomp, Inc. Announces Company Purchase From United Therapeutics
11. Reportlinker Adds Pain Therapeutics - Drugs, Markets and Companies
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:3/3/2015)... Mass. , March 3, 2015 Boston Scientific ... Charles J. Dockendorff and Stephen P. MacMillan ... Two current members of the board, Uwe E. Reinhardt ... for re-election at the company,s annual meeting of stockholders in ... was formerly the executive vice president and chief financial officer ...
(Date:3/3/2015)... , March 3, 2015   Surefire ... a prospective clinical trial comparing the Surefire Infusion System ... either primary or metastatic liver cancer, using the ... uptake of embolic agents, and with significantly decreased ... presented today at the Society of Interventional ...
(Date:3/3/2015)... 2015 Research and Markets ( http://www.researchandmarkets.com/research/x5lz9r/global_poc ... POC Diagnostics Market 2015-2019" report to their offering. ... POC Diagnostics market to grow at a CAGR of ... POC diagnostics are IVD devices and tools used for ... The use of these devices helps in the rapid ...
Breaking Medicine Technology:Boston Scientific Elects Charles J. Dockendorff And Stephen P. MacMillan To Board Of Directors 2Clinical Trial Comparing the Surefire Infusion Device to an End Hole Catheter Finds Surefire Increases Tumor Uptake and Decreases Non-Target Embolization In Every Patient, Multiple Liver Cancer Types 2Global POC Diagnostics Market 2015-2019 with Abbott Labs, Alere, Bayer Healthcare, Danaher, F. Hoffmann-La Roche & Johnson & Johnson Dominating 2
... 2007 - Pro-Pharmaceuticals,Inc. (Amex: PRW), a developer ... Eliezer Zomer, Ph.D., Executive Vice,President, Product Development ... Advanced Solid Tumors of,5-FU with an Admixture ... of Oncodevelopmental Biology and Medicine,(ISOBM) Conference to ...
... Investigative Dermatology, FREEPORT, N.Y., May 16, 2007 ... clinical data that indicates,that OCTN-1 skin cells ... L-ergothioneine (EGT) as a protector against oxidative,damage, ... more powerful and,efficient antioxidant than idebenone, scavenging ...
Cached Medicine Technology:Pro-Pharmaceuticals to Present Abstract at the International,Society of Oncodevelopmental Biology and Medicine Conference 2Pro-Pharmaceuticals to Present Abstract at the International,Society of Oncodevelopmental Biology and Medicine Conference 3Pro-Pharmaceuticals to Present Abstract at the International,Society of Oncodevelopmental Biology and Medicine Conference 4Pro-Pharmaceuticals to Present Abstract at the International,Society of Oncodevelopmental Biology and Medicine Conference 5AGI Dermatics Presents Comparative Data That Indicates OCTN-1 Skin,Cells Have the Ability to Recognize, Transport and Utilize,L-ergothioneine (EGT) As A Protector Against Oxidative Damage 2
(Date:3/3/2015)... 2015 The biggest name in indoor ... the world’s first fully integrated air quality platform that ... an air purifier to remove dust, pollen and hazardous ... control, via phone, tablet or computer. , Sweden’s Blueair, ... countries worldwide, will unveil its Internet-enabled air sensor together ...
(Date:3/3/2015)... SC (PRWEB) March 03, 2015 The ... the public’s expectation of excellence in care and safe ... the position of the RNS that biologic infusions are ... under the direct supervision of a registered nurse (RN), ... reactions, including anaphylaxis can occur in patients receiving these ...
(Date:3/3/2015)... 2015 In March, 1% for the ... kick off a new campaign, “Know Your Source,” which calls ... and ambassadors in their quest for ingredient awareness and better ... of its members and partners, including King Arthur Flour, Good ... to raise awareness for food as an environmental issue, with ...
(Date:3/3/2015)... The report “Alopecia – Pipeline Review, H1 2015? ... Alopecia is the loss of hair. Alopecia areata and ... Causes for alopecia include aging, genetics, illness, chemotherapy, malnutrition ... pattern hair loss, female diffuse hair loss, hairs easily ... focal or diffuse and by the presence or absence ...
(Date:3/3/2015)... US Air Purifiers LLC , an ... is pleased to announce that all Rabbit brand air purifiers ... to the west coast port strikes. This news comes just ... , The port strikes, which have caused ... quarter economic growth by as much as 1%, have hindered ...
Breaking Medicine News(10 mins):Health News:Smart sensor and air purifier interconnect to track and trap dust, pollen and dangerous particles in home and workplace air 2Health News:Administration of Biologic Infusions: A Position Statement of the Rheumatology Nurses Society 2Health News:1% For the Planet Asks Consumers to “Know Your Source” 2Health News:Alopecia Therapeutics Drugs and Companies Pipeline Market H1 2015 Review Report Available at RnRMarketResearch.com 2Health News:Alopecia Therapeutics Drugs and Companies Pipeline Market H1 2015 Review Report Available at RnRMarketResearch.com 3Health News:Alopecia Therapeutics Drugs and Companies Pipeline Market H1 2015 Review Report Available at RnRMarketResearch.com 4Health News:Rabbit Air Purifiers Back In Stock at US Air Purifiers LLC 2Health News:Rabbit Air Purifiers Back In Stock at US Air Purifiers LLC 3
... was halted early after risk of both recurrence and ... -- European researchers report more grim news concerning women ... run the risk of developing breast cancer while taking ... face a higher risk of a recurrence or a ...
... to be published in the American Journal of,Epidemiology, ... publication in the American Journal of Epidemiology, a team ... Michigan found,that women who ate the most fish (more ... pregnancies delivered children with the highest,scores on two cognitive ...
... year when more,than 1.5 million high school and college students ... large quantities of alcohol. Students who,vacation with friends over spring ... home with parents or relatives, according to a report in ... and Drugs., Instead of just telling students not to ...
... HILL, N.C., March 25 Successful brand leaders,know ... crucial and effective,strategies to optimize a product,s lifecycle., ... Promotion in,segmented sectors, and Clinical and Scientific Excellence ... a brand,s success and describes exactly,which costs need ...
... whites, study finds , , TUESDAY, March 25 (HealthDay News) -- ... blacks are much less likely to get colonoscopies than their ... who have an increased chance of developing colon cancer continue ... lack of a doctor referral stood out as the primary ...
... NEW YORK, March 25 For journalists covering,today,s release ... and,Medicare assessing the fiscal health of the government,s two ... budget),the authors of a popular book on the federal ... question: Are America,s leaders so immersed in,short term political ...
Cached Medicine News:Health News:HRT Raises Recurrence Risk Among Breast Cancer Survivors 2Health News:Study: Pregnant Women Who Eat More Fish, Including Canned Tuna, Have Smarter Children 2Health News:It's Spring Break: How Much Does Heavy Drinking Affect Your Body? 2Health News:Sales and Marketing Effectiveness in Pharmaceutical Companies Increases Brand Performance 2Health News:High-Risk Blacks Less Likely to Get Colonoscopies 2
... a national reference laboratory and a worldwide ... ARUP offers an extensive test menu of ... clinical and anatomic pathology. Owned by the ... more than half of the nation's university ...
... a national reference laboratory and a worldwide ... ARUP offers an extensive test menu of ... clinical and anatomic pathology. Owned by the ... more than half of the nation's university ...
... reference laboratory and a worldwide leader in ... an extensive test menu of highly complex ... anatomic pathology. Owned by the University of ... half of the nation's university teaching hospitals ...
... national reference laboratory and a worldwide leader ... offers an extensive test menu of highly ... and anatomic pathology. Owned by the University ... than half of the nation's university teaching ...
Medicine Products: